Met Tregs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

Fahroni shutterstockMulticentre clinical trialDiabetic patients hospitalised withTherapeutic immuneImage creditAtrial cardiopathyAntithrombotic drugsPrevention after cryptogenic strokeMet tregsCoronavirus disease covid 19Anti inflammatoryClinical trialGlycated hemoglobinImmune responseN vivoArs cov 2